Amarin Corporation plc
- AMRN
- NASDAQ
- Drug manufacturers
- Cardiovascular Drugs (Vascepa)
$11.53
Today +1.86%Quote Oct 19, 2026, 08:00 PM UTC
−18.39%over the last month
Max drawdown −18.4%From 1-month high −18.4%3 months −16.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Amarin
Amarin Corporation plc is a pharmaceutical firm dedicated to the research, development, and commercialization of therapeutic solutions for cardiovascular diseases. Its operations span several international regions, including the United States, Germany, Canada, Lebanon, and the United Arab Emirates.
Where the money comes from
Q2 2026 revenue $42.2M
- Product$39.1M92.6%
- Licensing And Royalty$3.1M7.4%
Sector
Healthcare
Industry
Drug manufacturers
Exchange
NASDAQ
Employees
80
Market value
$238.5M
Quote Oct 19
Floor
$11.29
2.0% below price
Resistance
$11.56
0.2% above price
Price vs analyst targets
18 analysts
Lowest target
$1.50Highest target
$3.00
$1.50Highest target
$3.00
- Price $11.53
- Average target $2.17
- Analysts' target range
The price is above even the highest analyst target. Analysts' average target sits about 81% lower. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about AMRNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free